Group 1 - The core point of the article highlights the performance of the 中证2000ETF华夏 (562660), which opened with a slight increase of 0.34%, priced at 1.746 yuan [1] - The fund's performance benchmark is the 中证2000 index return, managed by 华夏基金管理有限公司, with a return of 73.94% since its establishment on September 6, 2023, and a monthly return of 4.22% [1] Group 2 - The top holdings of 中证2000ETF华夏 include 天奥电子, 国恩股份, 亚太股份, 宝胜股份, 绿色动力, 春秋电子, 光电股份, 麦克奥迪, 杰普特, and 道恩股份, with varying performance on the opening day [1] - Specific stock performances on the opening day include 天奥电子 down 0.41%, 国恩股份 unchanged, 亚太股份 down 0.86%, 宝胜股份 down 1.84%, 绿色动力 up 0.29%, 春秋电子 up 0.12%, 光电股份 down 0.26%, 麦克奥迪 up 1.43%, 杰普特 up 0.23%, and 道恩股份 up 0.04% [1]

Group 1 - The China Securities 2000 Index has seen a significant increase, with Northern Long Dragon (301357) rising by 20.00% and other stocks like Xinhang New Materials and Haichang New Materials also experiencing gains [1] - The Huaxia China Securities 2000 ETF (562660) has achieved a 0.78% increase, marking its fourth consecutive rise, with the latest price reported at 1.54 yuan [1] - Over the past week, the Huaxia China Securities 2000 ETF has accumulated a total increase of 1.79%, indicating strong market performance [1] Group 2 - The trading volume for the Huaxia China Securities 2000 ETF was active, with a turnover rate of 10.09% and a transaction value of 28.05 million yuan [1] - The fund's scale has reached a new high of 276 million yuan, with the latest share count at 181 million, also a one-year peak [1] - Recent net inflows into the Huaxia China Securities 2000 ETF amounted to 12.19 million yuan, with a total of 33.13 million yuan net inflow over the last ten trading days [1] Group 3 - The National Healthcare Security Administration is optimizing drug procurement measures, with 55 drugs proposed for inclusion in the national procurement scope [2] - The WAIC indicates that AI in healthcare has entered a critical phase, with applications extending to cancer screening, critical condition management, and chronic disease management [2] - The China Securities 2000 Index focuses on small-cap stocks with high liquidity, emphasizing sectors like machinery, electronics, and biomedicine, which have significant growth potential [2]

Core Viewpoint - The small-cap stocks are regaining momentum, with the CSI 2000 Index showing a 0.42% increase, indicating a favorable environment for small-cap style investments despite recent valuation increases and potential short-term volatility [1] Group 1: Market Performance - As of July 7, the CSI 2000 Index rose by 0.42%, with notable stocks like China Shipbuilding Industry Corporation and Suwen Electric Power reaching their daily limit [1] - The CSI 2000 ETF (Hua Xia) increased by 0.36%, with a recent price of 1.4 yuan, and has seen a cumulative increase of 1.53% over the past week, ranking among the top comparable funds [1] Group 2: Market Environment - The current macroeconomic environment is still favorable for small-cap stocks, supported by ongoing trends in industries like AI and government policies focusing on "developing new productive forces" [1] - Structural issues such as weak real estate and insufficient domestic demand remain challenges, but there is potential for increased growth-stimulating policies in the second half of the year [1] Group 3: Valuation and Liquidity - As of June 27, the turnover rate for small-cap indices was 2.1%, indicating a relatively high trading density, while the small-cap to large-cap turnover ratio is approximately 4.1 times, close to historical averages [2] - The current price-to-earnings (P/E) ratio for small-cap indices compared to large-cap indices is 2.2 times, positioned at the 72.5 percentile since 2015, suggesting room for further small-cap performance [2] Group 4: Future Outlook - There is a possibility of a style switch between small and large caps as the fundamentals gradually stabilize and investor expectations for the economy improve [2] - The CSI 2000 ETF closely tracks the CSI 2000 Index, which focuses on small-cap stocks with high liquidity and growth potential, particularly in emerging industries like machinery, electronics, and biomedicine [2]